Literature DB >> 31312620

The Prevalence of Helicobacter Pylori babA, homB, aspA, and sabA Genes and Its Relationship with Clinical Outcomes in Turkey.

Nimet Yılmaz1, Meltem Koruk Özer2.   

Abstract

Background and Aims: The cag A and vac A genes of Helicobacter pylori (H. pylori) are closely associated with the pathogenicity of bacteria. However, the significance of H. pylori babA, homB, aspA, and sabA genes is not clear in phenotypic characteristics of virulence. This study aimed to investigate the frequency and importance of these genes in patients with H. pylori positive peptic ulcer (PU). Materials and
Methods: Patients with a PU or nonulcer dyspepsia (NUD) based on the upper gastrointestinal (UGI) endoscopy findings were included in the study. Biopsy samples from antrum and corpus were cultured into Columbia agar. H pylori were characterized by urease, catalase, oxidase test, and gram staining. Genomic DNA was extracted and stored. The babA, homB, aspA, and sabA genes were determined by using polymerase chain reaction analysis.
Results: A total 214 patients were included (99 PU and 115 NUD) and H. pylori could be isolated in 82 patients (36 PU and 46 NUD). The frequency of the babA (25% vs. 15.2%, p=0.25), homB (2.7% vs. 4.3%, p=1), aspA (69.4% vs. 73.9%, p=0.2), and sabA (2.7% vs. 10.8%, p=0.88) genotypes was not different between PU and NUD patients. There were some correlations between the presences of these genes.
Conclusion: This study managed to determine babA, homB, aspA, and sabA genes of H. pylori by PCR. However, the frequency of these factors was not different in patients with PU and NUD. There is no role of babA, homB, aspA, and sabA genes for the development of peptic ulcer in Turkish population.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31312620      PMCID: PMC6595381          DOI: 10.1155/2019/1271872

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


1. Introduction

Helicobacter pylori (H. pylori) is a gram-negative, spiral-shaped, 4-6-flagellated mobile bacterium that grows in the digestive tract and microaerophilic environment at 37°C in culture. The coccoid form of H. pylori is also called sleeping form. H. pylori produces urease that catalyzes the hydrolysis of urea to yield ammonia and carbonic acid. Flagella, urease, and adhesins are all essential factors for H. pylori to colonize the gastric mucosa [1]. H. pylori may be present in almost half of the world population. The incidence of H. pylori infection varies according to gender, race, and social and socioeconomic status of the population. The people who are living in developing countries are very commonly infected with H. pylori whereas the frequency of H. pylori infection is rare in Australia, Canada, and the USA [2]. The occurrences of new gastric cancer cases were variable in developing countries (8.4%) and developed countries (4.5%) [3]. Gastrointestinal cancer-related death rate is the third most common cause of all cancer-related deaths. H. pylori are correlated with the development of duodenal ulcer and gastric cancer. H. pylori infected individuals are having risk of developing peptic ulcer in 15-20%, gastric cancer in 1%, and primary gastric lymphoma in 0.1%. H. pylori infection is a high risk factor for the development of peptic ulcer, gastric maltoma, and adenocarcinoma [4]. Therefore, it may cause significant health problems. The transmission way of H. pylori has not been fully clear, yet [5]. H. pylori are adapted and colonize harsh, acidic environment of the stomach and survive in acidic environment that causes induction of gastritis, peptic ulcer, or gastric cancer. H. pylori is actually an opportunistic pathogen. Some virulence factors of H. pylori, such as cagA and vacA, are the most pathogenic factors among all virulence factors [6]. There are also some other genes of H. pylori such as babA, homB, aspA, and sabA the significance for pathogenicity of which is not clear yet. H. pylori adhesions such as the Lewis blood group antigen-binding adhesion (babA) and the sialic acid-binding adhesion (sabA) are considered to have a significant function on initial colonization of H. pylori [7, 8]. H. pylori outer-membrane proteins (hom) family is a small protein family including the C-terminal hydrophobic motif and signal sequences of outer membrane proteins. The hom family is one of the outer-membranes coding gene family that is divided into two families: homA and homB which are 90% identical; the difference is related to central domain [9]. Recent studies on adherence features of H. pylori have reported that babA promotes attachment of H. pylori to the gastric epithelial cells. The babA facilitates entry of cagA and vacA virulence factors into host cells [10, 11]. The second adhesion is sabA first identified in the babA-mutant H. pylori strain [8]. The sabA binds to sialylated carbohydrates on the surface of neutrophils. From this perspective, sabA is thought to promote immune response [11]. The aim of this study was to determine H. pylori babA, homB, aspA, and sabA genes and to identify the rate of these virulence genes in the biopsy samples by PCR analysis.

2. Materials and Methods

2.1. Collection of Biopsy Samples

A total of 214 patients were included in this study: 115 nonulcer dyspepsia and 99 peptic ulcer. The patients were from south east part of Turkey undergoing upper gastrointestinal endoscopy at the endoscopy unit of the Department of Gastroenterology, University of Gaziantep. During endoscopy, biopsy samples were taken and the obtained tissues were placed into 0.8% serum physiologic solution and then cultured immediately. Informed consent was taken from all patients and The Ethics Committee of Medical School of University of Gaziantep approved the study. Results were confirmed both clinically and microbiologically.

2.2. Microbiologic Analysis

2.2.1. Culturing

In order to prevent contamination, aseptic conditions were provided. The obtained tissues were immediately placed into a liquid 0.8% serum physiologic solution and inoculated into Columbia agar with 5% sheep blood (BD, Heidelberg, Germany), containing H. pylori selective supplement (OXOID LTD, Basingstoke, Hampshire, England) to eliminate another bacterial contamination, and then incubated under anaerobic conditions, 5% CO2 at 37°C for 4-6 days.

2.2.2. Urease, Catalase, and Oxidase Tests

To prove existence of H. pylori, catalase (Merck, Darmstadt, Germany), urease (Merck, Darmstadt, Germany), and oxidase (Merck, Darmstadt, Germany) tests were performed and also H. pylori morphology was identified.

2.2.3. Gram-Staining

To observe H. pylori under the light microscope, gram staining method was performed. Crystal violet (Merck, Darmstadt, Germany) was applied to heat-fixed smear of bacterial culture. Lugol (Merck, Darmstadt, Germany) that binds crystal violet was added. To decolorize it, ethanol (Merck, Darmstadt, Germany) was added and then stained with safranin (Merck, Darmstadt, Germany).

2.3. Genotyping of H. pylori

2.3.1. DNA Isolation

Genomic DNA was extracted from histopathologically confirmed cases of nonulcer dyspepsia and peptic ulcer using Qiagen DNA isolation kit Qiagen, QIAmp DNA Mini Kit (Hilden, Germany) according to manufacturer's instructions. The DNA was stored at -20°C until used for molecular studies.

2.3.2. PCR Analysis

Touchdown PCR protocols were performed using Dream Taq DNA Polymerase (Thermo Scientific, Lithuania, EU) kit. PCR amplifications were performed on 50 μl master mixture that contained 100 ng of genomic DNA, 10 pmole each of primers, 10X buffer, 2 mM each of nucleotides (Deoxynucleotide Triphosphate, Thermo Scientific, Lithuania, EU), and 0.5 units of Taq Polymerase. PCR annealing temperatures for primers of aspA, babA, cagA, homB, sabA, and vacA were 59°C, 55°C, 58°C, 58°C, 56°C, and 55°C, respectively. PCR products were then electrophoresed for 45 min at 130 Volt on 1% agarose gel in the presence of 0.5g/mL of ethidium bromide (Sigma, Steinheim, Germany) and illuminated under UV light (UVP EC3 imaging system, Upland, CA, USA).

2.3.3. Statistical Analysis

Comparisons of variables were performed with the chi-square test, One-way ANOVA test, and Tukey's Multiple Comparison Test (GraphPad Prism 5) to compare the differences among nonulcer dyspepsia and peptic ulcer patients. p values <0.05 were considered significant.

3. Results

Gastric biopsies from all patients included in the study were cultured and initially assessed for the presence of H. pylori by urease, catalase, and oxidase tests. As a result of these tests, H. pylori were detected in 82 patients (38.32%), whereas bacteria could not be detected in 132 patients (61.68%). All H. pylori-positive patients (82) were further analyzed for the presence of H. pylori virulence factors by PCR using babA, homB, aspA, and sabA-specific primers encoding (Table 1(a)) babA, homB, aspA, and sabA genes (Figure 1).
Figure 1

Characterization of virulence factors of H. pylori by PCR. Each lane shows different virulence factors of H. pylori strain isolated from human samples. M: Marker, A: babA (2192 bp), B: cagA (1741 bp), C: VacA (1624 bp), D: AspA (1401 bp), E: HomB (1005 bp), and F: sabA (187 bp).

A total of 82 H. pylori-positive patients (46 nonulcer dyspepsia (25 females, 21 males) and 36 peptic ulcer (16 females, 20 males)) were enrolled in this study (Table 1(b)). The mean age of the overall population was 45.7±16.5 years. There were significant relationships between gender and the nonulcer dyspepsia and peptic ulcer diseases related to these virulence factors (p<0.001). However, there were no significant differences in mean age (p>0.05).

3.1. Virulence Factors

(i) Blood Group Antigen-Binding Adhesin, babA. The babA gene of H. pylori was determined in 16 patients (19.51%), whereas 66 patients (80.49%) were classified as babA-negative (Table 1(c)). Out of 16 babA gene positive patients, 7 of them (43.75%) were from nonulcer dyspepsia patients and 9 of them (56.25%) were from peptic ulcer patients (Table 1(b)). The presence of babA was statistically significant in nonulcer dyspepsia (p < 0.001) and peptic ulcer (p < 0.001) (Table 2(b)) (Figures 2(a)–2(g)).
Figure 2

PCR application of the biopsy samples taken from H. pylori positive patients with nonulcer and gastric ulcer samples. The presence of AspA (a), BabA (b), VacA (c), HomB (d), CagA (e), and SabA (f) genes in nonulcer and gastric ulcer samples by using PCR. (g) The comparison of H. pylori virulence factors in normal and gastric ulcer samples.

(ii) Helicobacter Outer Membrane Family Member, homB. The 1005-bp PCR product indicating the presence of homB gene was detected in 3 patients (3.66%), whereas 79 patients (96.34%) were negative for homB gene (Table 2(a)). Out of 3 homB-positive strains, 2 isolates (66.6%) were from nonulcer dyspepsia patient and 1 isolate (33.3%) was from patient diagnosed with peptic ulcer disease. The presence of homB was associated with the presence of aspA (p <0.001) and babA (p <0.05) (Table 2(a)). A statistically significant correlation between homB and aspA and babA gene was detected. Moreover, the status of homB had significant effect on nonulcer dyspepsia (p < 0.001) and peptic ulcer patients (p < 0.001) (Figure 2(d)) (Figures 2(a)–2(g)). (iii) Aspartate Ammonia-Lyase, aspA. Fifty-nine biopsies that were obtained from different patients (71.94%) were positive for the aspA gene, with the remaining 23 (28.04%) being aspA-negative as a result of the 1401-bp PCR product (Table 1(c)). Out of 59 aspA-positive strains, 34 isolates (57.62%) were from nonulcer dyspepsia patients, and 25 isolates (42.38%) were from patients diagnosed with peptic ulcer disease. The frequency of aspA (71.95%) (p<0.0001) was significantly higher compared to the frequency of babA (19.51%), homB (3.65%), and sabA (7.31%) in nonulcer dyspepsia and peptic ulcer patients. The presence of aspA was associated with the presence of babA, homB, and sabA (p < 0.0001) (Table 2(a)). There was a positive correlation between aspA and babA, homB, sabA, and vacA genes. The presence of aspA had statistically significant impact on nonulcer dyspepsia (p < 0.001) and peptic ulcer (p < 0.001) (Table 2(b)) (Figures 2(a)–2(g)). (iv) Sialic Acid-Binding Adhesin, SabA. The 187-bp PCR product indicating the presence of sabA gene of H. pylori was determined in 6 patients (7.31%), whereas 76 patients (92.69%) were classified as sabA-negative (Table 1(c)). Out of 6 sabA-positive patients, 5 of them (83.33%) were from nonulcer dyspepsia patients and 1 of them (16.66%) was from peptic ulcer patient. The presence of sabA was just associated with the presence of aspA (p < 0.001). Furthermore, the presence of sabA gene had significant effect on nonulcer dyspepsia (p < 0.001) and peptic ulcer (p < 0.001) (Table 2(b)) (Figure 2(f)). Possible combinations of all of these virulence factors were determined in Turkish population (Figures 2(a)–2(g)).

4. Discussion

H. pylori is a gram-negative bacillus which causes gastritis, peptic ulcer, and gastric cancer [12]. The prevalence of H. pylori depends on geographic regions, age, social and economic status, occupation, and living environment [6, 13]. H. pylori have genetically diverse strains, and the strains differ in virulence [14]. In this study, the distribution of aspA, babA, homB, and sabA genes in H. pylori isolated from patients suffering from gastroduodenal diseases in Turkey determined using PCR analysis and the relationship between these virulence factors was assessed. Studies have reported that there is a relationship between babA-positive H. pylori and gastric inflammation in humans. Furthermore, the babA-positive H. pylori increased risk of peptic ulcer and gastric cancer in humans [15, 16]. The babA gene has been detected on the outer membrane of the H. pylori strain. It has been shown that the babA is able to induce DNA double-strand breaks (DSBs) in the cells, but DSBs are the strictest type of DNA destruction and can cause chromosomal aberrations, such as deletions, insertions, and translocations resulting in loss of heterozygosity which are hallmarks of gastric cancer [17]. H. pylori strains that were isolated from East Asia expressed babA gene but H. pylori strains from 24 western countries did not express babA gene. These bacterial strains caused mild gastric problem. A meta-analysis review revealed that the existence of babA is correlated with high risk of peptic ulcer (OR = 2.069), especially the duodenal ulcer (OR = 1.588). This type of association was observed only in Western countries and not in Asian countries [18]. During the first 2-12 weeks during the experimental H. pylori infection, the babA expression disappeared in the experimental animals [19, 20]. H. pylori that was isolated from patient samples showed incredible variety at the babA locus, which can translate distinct adhesin that binds only blood group (O/Leb, or A/ALeb and B/BLeb) [21]. We have also observed the same results as documented in literatures. The babA expression is a dynamic process. The vigorous and variety nature of host glycosylation adds extra complexity. It has been shown that loss of babA expression associated with gender. For this conclusion, the mice model has been used [22]. The oorA, scoD, aroQ, fld A, and aspA of H. pylori proteins are thought to hypothetically interact. It is deduced that these proteins also play a role in oxidation reduction [23]. Significant increase in protein with antioxidant activity (aroQ, aspA, fldA, icd, OorA, and scoB) and high acid environment adaptation proteins (katA and napa) in H. pylori has been shown to be high [23]. It has been shown that an increase in the expression of three genes encoding enzymes involved in intrabacterial ammonia production was observed. The genes are amidase amiE and amiF and aspA. These enzymes can help neutralize the protons entering under acidic environmental conditions by producing intrabacterial ammonia. This study revealed that aspA is taking part in intrabacterial ammonia production [24]. The cytotoxin-associated gene (cagA) and vacuolating cytotoxin (vacA) are H. pylori virulence factors and associated with gastric ulcer, gastric cancer [25, 26]. However, it has been documented that there is no difference between the presence of the homB gene and severe gastric diseases [27]. Besides, the disease reason has been correlated with many outer membrane proteins (OMPs). Particularly, the outer membrane proteins of H. pylori such as alpA, alpB, babA, homB, hopZ, oipA, and sabA are all correlated with variable disease outcomes [28]. H. pylori has a high content of simple sequence repeats, mainly in genes encoding outer membrane proteins [29]. The cagA and vacA are polymorphic genes. The outer membrane proteins families are strictly correlated paralogs. For instance, the bab- genes family consists of three paralogs babA, babB, and babC. These paralog H. pylori genes can be located at three different chromosomal loci [30]. During infection and an increase of H. pylori colonization, homB, outer membrane protein, is very crucial for adherence of the H. pylori to the gastric epithelium. A statistically significant correlation between homB and aspA (p < 0.0001) and babA (p< 0.05) gene was detected in this study. On the other hand, there was no significant relationship between homB and sabA gene according to this study [31]. The hom gene family is a small paralogous protein. The homB and homA genes are almost the same which are 90% [24]. The homB was observed more often than homA in East Asia. The homB was correlated with an enlarged risk of peptic ulcer disease in East Asia. The homB has a role in proinflammation. The homB was important for bacterial attachment to host cell surface [9]. There are many different adhesion components existing on H. pylori to bind carbohydrates. The sabA has vital and important role in the primary colonization of H. pylori. H. pylori sabA proteins are also taking part in stable infections and development of chronic inflammation which directs to tissue damage [32]. H. pylori sabA is a diversity gene. The sabA gene has been associated with different stomach diseases such as 100% in gastric cancer, 86.7% in gastric ulcer, and 83.3% in gastritis and duodenal ulcer [33]. In conclusion, virulence factors of H. pylori gene sequences might differ markedly from other regions or other countries. These differences are detectable by PCR analysis and sequencing. These data suggest that virulence factor variants may present new markers for other factors involved in gastric carcinogenesis or probably influencing the result of H. pylori infection [34].
(a)
PrimerPrimer sequenceAnnealing Temperature (°C)Primer LengthProduct Size (bp)
AspA-FATGCGTATGGAGCATGATTTCATT55.9241401
AspA-RTTTATGCTTTTTGAAAGCGTGAGGGCTT62.228

BabA-FATGAAAAAACACATCCTTTCATTA52.5242192
BabA-RTTATTCAAATACACGCTATAGAGTCTT57.427

CagA-FAATACACCAACGCCTCCAAG57.3201741
CagA-RGCTGACAAAGGAGCACTTCC59.420

HomB-FTACAGACGCTCAAGGCAATG57.3201005
HomB-RTCTATGGGTAGGGCGTTTTG57.320

SabA-FCTCTCTCTCGCTTGCGGTAT59.420187
SabA-RTTGAATGCTTTGCCTCAATG53.220

VacA-FACAAACACACCGCAAAATCA53.2201624
VacA-FAACGGCCACATTAGTGGAAG57.320
(b)
GenderKind of diseaseNumber of patientsAspA+BabA+CagA+HomB+ SabA+VacA+Mean Age
MaleNS21163212439.85±17.11
GU20156001649.4±17.82
FemaleNS25185113447.52±17.01
GU1693010645.93±12.28
(c)
NSGUTotal p value
Number of patients463682-
AspA 34 (73.91%)25 (69.44%)59 (71.95%)<0.05
BabA 7 (15.21%)9 (25%)16 (19.51%)ns
CagA 3 (6.52%)0 (0%)3 (3.65%)ns
HomB 2 (4.34%)1 (2.77%)3 (3.65%)ns
SabA 5 (10.86%)1 (2.77%)6 (7.31%)ns
VacA 12 (26.08%)8 (22.22%)20 (24.39%)ns
(a)
Comparison p value95% CI
CagA vs HomB ns-0.18 to 0.13
CagA vs SabA ns-0.14 to 0.16
CagA vs AspA <0.00010.50 to 0.81
CagA vs BabA <0.050.002 to 0.31
CagA vs VacA <0.050.002 to 0.314
HomB vs SabA ns-0.11 to 0.19
HomB vs AspA <0.00010.52 to 0.83
HomB vs BabA <0.050.02 to 0.33
HomB vs VacA <0.050.02 to 0.33
SabA vs AspA <0.00010.49 to 0.80
SabA vs BabA ns-0.009 to 0.302
SabA vs VacA ns-0.009 to 0.302
AspA vs BabA <0.0001-0.65 to -0.34
AspA vs VacA <0.0001-0.65 to -0.34
BabA vs VacA ns-0.15 to 0.15
(b)
NSGU
AspA <0.0001<0.0001
BabA <0.001<0.001
CagA <0.001>0.05
HomB <0.001<0.001
SabA <0.001<0.001
VacA <0.001<0.001
  34 in total

1.  Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline.

Authors:  R H Hunt; S D Xiao; F Megraud; R Leon-Barua; F Bazzoli; S van der Merwe; L G Vaz Coelho; M Fock; S Fedail; H Cohen; P Malfertheiner; N Vakil; S Hamid; K L Goh; B C Y Wong; J Krabshuis; A Le Mair
Journal:  J Gastrointestin Liver Dis       Date:  2011-09       Impact factor: 2.008

Review 2.  Gastric Cancer as Preventable Disease.

Authors:  Massimo Rugge; Robert M Genta; Francesco Di Mario; Emad M El-Omar; Hashem B El-Serag; Matteo Fassan; Richard H Hunt; Ernst J Kuipers; Peter Malfertheiner; Kentaro Sugano; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2017-05-19       Impact factor: 11.382

3.  BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity.

Authors:  Nozomi Ishijima; Masato Suzuki; Hiroshi Ashida; Yusuke Ichikawa; Yumi Kanegae; Izumu Saito; Thomas Borén; Rainer Haas; Chihiro Sasakawa; Hitomi Mimuro
Journal:  J Biol Chem       Date:  2011-05-19       Impact factor: 5.157

4.  Expression of the BabA adhesin during experimental infection with Helicobacter pylori.

Authors:  Cathy M Styer; Lori M Hansen; Cara L Cooke; Amy M Gundersen; Sung Sook Choi; Douglas E Berg; Mohammed Benghezal; Barry J Marshall; Richard M Peek; Thomas Borén; Jay V Solnick
Journal:  Infect Immun       Date:  2010-02-01       Impact factor: 3.441

5.  Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation.

Authors:  Jafar Mahdavi; Berit Sondén; Marina Hurtig; Farzad O Olfat; Lina Forsberg; Niamh Roche; Jonas Angstrom; Thomas Larsson; Susann Teneberg; Karl-Anders Karlsson; Siiri Altraja; Torkel Wadström; Dangeruta Kersulyte; Douglas E Berg; Andre Dubois; Christoffer Petersson; Karl-Eric Magnusson; Thomas Norberg; Frank Lindh; Bertil B Lundskog; Anna Arnqvist; Lennart Hammarström; Thomas Borén
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

6.  Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production.

Authors:  Yoshio Yamaoka; Shogo Kikuchi; Hala M T el-Zimaity; Oscar Gutierrez; Michael S Osato; David Y Graham
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

7.  Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin.

Authors:  Marina Aspholm-Hurtig; Giedrius Dailide; Martina Lahmann; Awdhesh Kalia; Dag Ilver; Niamh Roche; Susanne Vikström; Rolf Sjöström; Sara Lindén; Anna Bäckström; Carina Lundberg; Anna Arnqvist; Jafar Mahdavi; Ulf J Nilsson; Billie Velapatiño; Robert H Gilman; Markus Gerhard; Teresa Alarcon; Manuel López-Brea; Teruko Nakazawa; James G Fox; Pelayo Correa; Maria Gloria Dominguez-Bello; Guillermo I Perez-Perez; Martin J Blaser; Staffan Normark; Ingemar Carlstedt; Stefan Oscarson; Susann Teneberg; Douglas E Berg; Thomas Borén
Journal:  Science       Date:  2004-07-23       Impact factor: 47.728

8.  Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins.

Authors:  H Ota; J Nakayama; M Momose; M Hayama; T Akamatsu; T Katsuyama; D Y Graham; R M Genta
Journal:  Virchows Arch       Date:  1998-11       Impact factor: 4.064

Review 9.  Genetic host factors in Helicobacter pylori-induced carcinogenesis: Emerging new paradigms.

Authors:  Michiel C Mommersteeg; Jun Yu; Maikel P Peppelenbosch; Gwenny M Fuhler
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-11-24       Impact factor: 10.680

10.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

View more
  1 in total

Review 1.  Kinases and therapeutics in pathogen mediated gastric cancer.

Authors:  Charu Sonkar; Nidhi Varshney; Siva Koganti; Hem Chandra Jha
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.